Down’s syndrome is the most commonly occurring genetic abnormality, involving about 1 in 600 births. The increasing life expectancy of individuals with Down’s syndrome has revealed the presence of several unexpected pathological processes. Among these, ENT disorders hold an important place because of their high incidence and severity. Accurate knowledge of the pathophysiology underlying ENT disorders (facial dysmorphism, ear abnormalities, upper airway abnormalities, and immunodeficiency) allow an understanding of the reasons for the development of the upper airway obstruction, obstructive sleep apnea syndrome, subglottic stenosis, deafness, speech delay, and ENT infections that occur frequently in these children. Early screening and specific treatment may allow some of the long-term sequelae to be avoided, or at least their prognosis to be improved. In order to help health care professionals in their daily practice, this review makes a series of recommendations to allow them to develop a master plan for the ENT management of children with Down’s syndrome. In children with Down’s syndrome, ENT disorders occur frequently and are often severe They develop owing to craniofacial, functional, and immune system abnormalities. Early screening and treatment allow improvements in long-term outcomes.
Get full access to this article
View all access options for this article.
References
1.
Sassouni V, Forrest E. Dentofacial pathology related to malocclusion. Orthodontics in Dental Practice. St. Louis: Mosby; 1971:169-197.
2.
Boseley ME, Link DT, Shott SR, Fitton CM, Myer CM, Cotton RT. Laryngotracheoplasty for subglottic stenosis in Down Syndrome children: the Cincinnati experience. Int J Pediatr Otorhinolaryngol. 2001;57(1):11-15.
3.
Goodman R, Gorlin R. The malformed infant and child: an illustrated guide. New York: Oxford University; 1983:122-123.
4.
Balkany TJ, Downs MP, Jafek BW, Krajicek MJ. Hearing loss in Down’s syndrome. A treatable handicap more common than generally recognized. Clin Pediatr (Phila). 1979;18(2):116-118.
Hassmann E, Skotnicka B, Midro AT, Musiatowicz M. Distortion products otoacoustic emissions in diagnosis of hearing loss in Down’s syndrome. Int J Pediatr Otorhinolaryngol. 1998;45(3):199-206.
7.
Shibahara Y, Sando I. Congenital anomalies of the eustachian tube in Down’s syndrome. Histopathologic case report. Ann Otol Rhinol Laryngol. 1989;98(7 Pt 1):543-547.
8.
Shott SR, Joseph A, Heithaus D. Hearing loss in children with Down’s syndrome. Int J Pediatr Otorhinolaryngol. 2001;61(3):199-205.
9.
Harada T, Sando I. Temporal bone histopathologic findings in Down’s syndrome. Arch Otolaryngol. 1981;107(2):96-103.
10.
Balkany TJ, Mischke RE, Downs MP, Jafek BW. Ossicular abnormalities in Down’s syndrome. Otolaryngol Head Neck Surg. 1979;87(3):372-384.
11.
Keiser H, Montague J, Wold D, Maune S, Pattison D. Hearing loss of Down’s syndrome adults. Am J Ment Defic. 1981;85(5):467-472.
12.
Schwartz DM, Schwartz RH. Acoustic impedance and otoscopic findings in young children with Down’s syndrome. Arch Otolaryngol. 1978;104(11):652-656.
13.
Bilgin H, Kasemsuwan L, Schachern PA, Paparella MM, Le CT. Temporal bone study of Down’s syndrome. Arch Otolaryngol Head Neck Surg. 1996;122(3):271-275.
14.
Schuknecht HF. Pathology of the ear. Lea and Febiger. 2nd Edition. Philadelphia; 1993:177-183.
15.
Walby AP, Schuknecht HF. Concomitant occurrence of cochleosaccular dysplasia and Down’s syndrome. Arch Otolaryngol. 1984;110(7):477-479.
16.
Igarashi M, O-Uchi T, Isago H, Wright WK. Utricular and saccular volumetry in human temporal bones. Acta Otolaryngol. 1983;95(1-2):75-80.
17.
Krmpotic-Nemanic J. Down’s syndrome and presbyacusis. Lancet. 1970;2(7674):670-671.
18.
Brown PM, Lewis GT, Parker AJ, Maw AR. The skull base and nasopharynx in Down’s syndrome in relation to hearing impairment. Clin Otolaryngol. 1989;14(3):241-246.
19.
Jacobs IN, Gray RF, Todd NW. Upper airway obstruction in children with Down’s syndrome. Arch Otolaryngol Head Neck Surg. 1996;122(9):945-950.
20.
Kobel M, Creighton RE, Steward DJ. Anaesthesic considerations in Down’s syndrome. Br J Anaesth. 1983;55:53-54.
21.
Hardcastle WJ, Morgan Barry RA, Clark CJ. An instrumental phonetic study of lingual activity in articulation-disordered children. J Speech Hear Res. 1987;30:171-184.
22.
Ludemann JP, Hughes CA, Noah Z, Holinger LD. Complications of pediatric laryngotracheal reconstruction: prevention strategies. Ann Otol Rhinol Laryngol. 1999;108(11 Pt 1):1019-1026.
23.
Miller R, Gray SD, Cotton RT, Myer CM 3rd, Netterville J. Subglottic stenosis and Down’s syndrome. Am J Otolaryngol. 1990;11(4):274-277.
24.
Nespoli L, Burgio GR, Ugazio AG, Maccario R. Immunological features of Down’s syndrome: a review. J Intellect Disabil Res. 1993;37(Pt 6):543-551.
25.
Mills EL, Quie PG. Congenital disorders of the function of polymorphonuclear neutrophils. Rev Infect Dis. 1980;2(3):505-517.
26.
Ugazio AG, Maccario R, Notarangelo LD, Burgio GR. Immunology of Down’s syndrome: a review. Am J Med Genet. 1990;7(suppl):204-212.
27.
Bess FH. The minimally hearing-impaired child. Ear Hear. 1985;6(1):43-47.
28.
Brooks DN, Wooley H, Kanjilal GC. Hearing loss and middle ear disorders in patients with Downs syndrome (mongolism). J Ment Defic Res. 1972;16(1):21-29.
29.
Dahle AJ, McCollister FP. Hearing and otologic disorders in children with Down syndrome. Am J Ment Defic. 1986;90(6):636-642.
30.
Kattan HA, Jarrar RF, Mahasin ZZ. A pilot study of the relationship between Down’s syndrome and hearing loss. Saudi Med J. 2000;21(10):931-933.
31.
Maroudias N, Economides J, Christodoulou P, Helidonis E. A study on the otoscopical and audiological findings in patients with Down’s syndrome in Greece. Int J Pediatr Otorhinolaryngol. 1994;29(1):43-49.
32.
Harigai S, Nagai K, Nakamura Y, Iino Y, Tanaka Y. Hearing impairment and otitis media with effusion in Down’s syndrome. In: recent advances in otitis media. Kugler, Amsterdam/New York, 1994:811-815.
33.
Iino Y, Imamura Y, Harigai S, Tanaka Y. Efficacy of tympanostomy tube insertion for otitis media with effusion in children with Down’s syndrome. Int J Pediatr Otorhinolaryngol. 1999;49(2):143-149.
34.
Buchanan LH. Early onset of presbyacusis in Down syndrome. Scand Audiol. 1990;19(2):103-110.
35.
Roizen NJ, Martich V, Ben-Ami T, Shalowitz MU, Yousefzadeh DK. Sclerosis of the mastoid air cells as an indicator of undiagnosed otitis media in children with Down’s syndrome. Clin Pediatr (Phila). 1994;33(7):439-443.
36.
Kavanagh KT, Kahane JC, Kordan B. Risks and benefits of adenotonsillectomy for children with Down’s syndrome. Am J Ment Defic. 1986;91(1):22-29.
37.
Pappas DG, Flexer C, Shackelford L. Otological and habilitative management of children with Down’s syndrome. Laryngoscope. 1994;104(9):1065-1070.
38.
Venail F, Roux AF, Pallarez-Ruiz N, Claustres M, Blanchet P, Mondain M. 35delG mutation in connexin 26 in association with non-syndromic sensorineural deafness: about two case reports. Laryngoscope. 2004;114(3):566-569.
39.
Dobie RA, Berlin CI. Influence of otitis media on hearing and development. Ann Otol Rhinol Laryngol. 1979;88(5 Pt 2 Suppl 60):48-53.
40.
Libb JW, Dahle A, Smith K, McCollister FP, McLain C. Hearing disorder and cognitive function of individuals with Down’s syndrome. Am J Ment Defic. 1985;90(3):353-356.
41.
Chapman RS, Hesketh LJ. Language, cognition, and short-term memory in individuals with Down syndrome. Downs Syndr Res Pract. 2001;7(1):1-7.
42.
Jarrold C, Baddeley AD, Phillips C. Down’s syndrome and the phonological loop: the evidence for, and importance of, a specific verbal short-term memory deficit. Down’s Syndr Res Pract. 1999;6(2):61-75.
43.
Baddeley A. Working memory. Science. 1992;255(5044):556-559.
44.
Jenkins C. Expressive language delay in children with Down’s syndrome: a specific cause for concern. Downs Syndr Res Pract. 1993;1:10-14.
45.
Szempruch J, Jacobson JW. Evaluating facilitated communications of people with developmental disabilities. Res Dev Disabil. 1993;14(4):253-264.
46.
Buckley S, Sacks B. The Adolescent with Down’s Syndrome—life for the teenager and for the family. Portsmouth Down’s Syndrome Trust: Portsmouth1987.
47.
Hamilton C. Investigation of the articulatory patterns of young adult with Down’s syndrome using electropalatography. Downs Syndr Res Pract. 1993;(1)1:15-28.
Hamlet SL, Bunnell HT, Struntz B. Articulation asymmetries. J Acoust Soc Am. 1986;79(4):1164-1169.
50.
Pryce M. The voice of people with Down’s syndrome: an EMG biofeedback study. Down’s Syndr Res Pract. 1994;2(3):106-111.
51.
Bennetts LK, Flynn MC. Improving the classroom listening skills of children with Down’s syndrome by using sound-field amplification. Down’s Syndr Res Pract. 2002;8(1):19-24.
52.
Marcus CL, Keens TG, Bautista DB, von Pechmann WS, Ward SL. Obstructive sleep apnea in children with Down’s syndrome. Pediatrics. 1991;88(1):132-139.
53.
de Jong AL, Sulek M, Nihill M, Duncan NO, Friedman EM. Tenuous airway in children with trisomy 21. Laryngoscope. 1997;107(3):345-350.
54.
Bell RB, Turvey TA. Skeletal advancement for the treatment of obstructive sleep apnea in children. Cleft Palate Craniofac J. 2001;38(2):147-154.
55.
Hilton JM, Fitzgerald DA, Cooper DM. Respiratory morbidity of hospitalized children with Trisomy 21. J Paediatr Child Health. 1999;35(4):383-386.
56.
Barnet AB, Weiss IP, Aysun S, Bernardo EB, Saumwege RW, Hines A. Hearing loss in infants with Down’s syndrome. Paediatric Research. 1988;25:289-292.
57.
National Deaf Children’s Society. Guidelines for early identification of hearing impairment. In: Quality Standards in Paediatric Audiology. Volume 1. 1994. London, National Deaf Children’s Society.
58.
Marder E, Dennis J. Medical management of children with Down’s syndrome. Current Paediatrics. 2001;(11):57-63.
59.
Flexer C, Gans DP. Distribution of auditory response behaviours in normal infants and profoundly multihandicapped children. J Speech Hear Res. 1986;29(3):425-429.
60.
Flexer C, Gans DP. Comparative evaluation of the auditory responsiveness of normal infants and profoundly multihandicapped children. J Speech Hear Res. 1985;28(2):163-168.
